The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
Authors
Keywords
-
Journal
Molecular Cancer
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-30
DOI
10.1186/s12943-019-1086-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway
- (2019) Qing-Feng Xiang et al. Artificial Cells Nanomedicine and Biotechnology
- Forkhead box O3 promotes colon cancer proliferation and drug resistance by activating MDR1 expression
- (2019) Zhuanglei Gao et al. Molecular Genetics & Genomic Medicine
- Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression
- (2019) Liangliang Shi et al. Cell Death & Disease
- A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
- (2019) Yufeng Wang et al. Molecular Cancer
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145
- (2019) Rongrong Gao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis
- (2019) Donglei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression
- (2019) Peichen Zhang et al. GENE
- Small nucleolar RNA U2_19 promotes hepatocellular carcinoma progression by regulating Wnt/β-catenin signaling
- (2018) Haitao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma
- (2018) Xue-Mei Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis
- (2018) Binghua Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
- (2018) Tanmoy Mondal et al. CANCER CELL
- Circulating PIWI-interacting RNAs piR-5937 and piR-28876 are promising diagnostic biomarkers of colon cancer
- (2018) Petra Vychytilova-Faltejskova et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Apigenin sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis
- (2018) Ai-Mei Gao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway
- (2018) Ju-Min Chen et al. IUBMB LIFE
- MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway
- (2018) Tao Tian et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
- (2018) Kai Zhang et al. Cell Death & Disease
- The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma
- (2018) Daniela Pollutri et al. Cell Death & Disease
- Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma
- (2018) Yingbin Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
- (2018) Hailong Mi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis
- (2018) Chuanyou Yi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma
- (2018) Peng-Fei Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
- (2018) Minjiang Chen et al. EBioMedicine
- Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway
- (2018) Yangwei Fan et al. CANCER BIOLOGY & THERAPY
- LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
- (2018) Linmei Wang et al. CANCER BIOLOGY & THERAPY
- Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma
- (2018) Yun Lou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma
- (2018) Ke-ting Que et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
- (2018) Yuan Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data
- (2018) Xin-gan Qin et al. PATHOLOGY RESEARCH AND PRACTICE
- Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process
- (2018) Hongli Gao et al. OncoTargets and Therapy
- Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy
- (2018) Meng Wang et al. Cell Death & Disease
- LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1
- (2018) Cong Shi et al. MEDICAL SCIENCE MONITOR
- Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Bladder Cancer Diagnosis and Prognosis
- (2018) Jiansong Wang et al. MEDICAL SCIENCE MONITOR
- The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI
- (2018) Feng Xing et al. Molecular Therapy-Oncolytics
- Mifepristone potentiates etoposide toxicity in Hep G2 cells by modulating drug transport
- (2018) Z. Dostál et al. TOXICOLOGY IN VITRO
- A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma
- (2018) Wen-Jie Wang et al. JOURNAL OF SURGICAL RESEARCH
- Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells
- (2017) Xin Yin et al. GENE
- A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma
- (2017) Tasnuva D. Kabir et al. HEPATOLOGY
- Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway
- (2017) Yaling Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
- (2017) H Xiong et al. ONCOGENE
- Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma
- (2017) Ai-Qing Lu et al. ONCOLOGY REPORTS
- MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells
- (2017) Chaohui Zuo et al. TUMOR BIOLOGY
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy
- (2016) Peng Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
- (2016) Yanmin Xu et al. CANCER LETTERS
- miR-181a induces sorafenib resistance of hepatocellular carcinoma cells through downregulation of RASSF1 expression
- (2016) Junya Azumi et al. CANCER SCIENCE
- From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
- (2016) Sonam Dhamija et al. INTERNATIONAL JOURNAL OF CANCER
- HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells
- (2016) Zhihao Wang et al. MEDICAL ONCOLOGY
- Long non-coding RNA TUC338 is functionally involved in sorafenib-sensitized hepatocarcinoma cells by targeting RASAL1
- (2016) Weidong Jin et al. ONCOLOGY REPORTS
- miR-503 inhibits proliferation making human hepatocellular carcinoma cells susceptible to 5-fluorouracil by targeting EIF4E
- (2016) Xiaoyan Yang et al. ONCOLOGY REPORTS
- Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology
- (2016) Jeonghun Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals
- (2016) Junjie Xu et al. EBioMedicine
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism
- (2016) Chenwei Pan et al. PLoS One
- miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway
- (2015) Liang Shi et al. Asian Pacific Journal of Cancer Prevention
- miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
- (2015) Wenjing Mu et al. CELL RESEARCH
- MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil
- (2015) Liang Shi et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Systemic Therapy of Hepatocellular Carcinoma
- (2015) Aparna Kalyan et al. Clinics in Liver Disease
- Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
- (2015) Yangyang Ou et al. GENE
- Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer
- (2015) Yoshinaga Okugawa et al. GUT
- miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targetingCLDN10andCITRON
- (2015) Huiyan Sun et al. HEPATOLOGY RESEARCH
- Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1
- (2015) Jin Ma et al. JOURNAL OF DRUG TARGETING
- MicroRNA-133a and microRNA-326 co-contribute to hepatocellular carcinoma 5-fluorouracil and cisplatin sensitivity by directly targeting B-cell lymphoma-extra large
- (2015) JIN MA et al. Molecular Medicine Reports
- MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues
- (2015) LI WANG et al. Molecular Medicine Reports
- MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1
- (2015) HAIFEI HE et al. Molecular Medicine Reports
- Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
- (2015) KAI LIU et al. ONCOLOGY REPORTS
- Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy
- (2015) LIYU CHEN et al. Oncology Letters
- microRNA-4717 differentially interacts with its polymorphic target in the PD1 3’ untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases
- (2015) Guoyu Zhang et al. Oncotarget
- Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine
- (2015) Takahiro Kishikawa et al. Oncotarget
- MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A
- (2015) Katsuya Ohta et al. Oncotarget
- Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib
- (2014) Kai Mao et al. CANCER LETTERS
- The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
- (2014) Thomas R. Cech et al. CELL
- Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1
- (2014) Jun Qin et al. GENE
- miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma
- (2014) KAI LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Decreased Expression of Hepatocyte Nuclear Factor 4α (Hnf4α)/MicroRNA-122 (miR-122) Axis in Hepatitis B Virus-associated Hepatocellular Carcinoma Enhances Potential Oncogenic GALNT10 Protein Activity
- (2014) Qian Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3
- (2014) Na Zhao et al. Molecular Cancer
- Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy
- (2014) Kenji Takahashi et al. MOLECULAR CANCER RESEARCH
- Role and mechanisms of microRNA-503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells
- (2014) DONG WANG et al. Molecular Medicine Reports
- Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II
- (2014) JIAN-XIN JIANG et al. Molecular Medicine Reports
- MiR-338-3p Inhibits Hepatocarcinoma Cells and Sensitizes These Cells to Sorafenib by Targeting Hypoxia-Induced Factor 1α
- (2014) Haitao Xu et al. PLoS One
- Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
- (2014) R Sonntag et al. Cell Death & Disease
- Directionality of noncoding human RNAs: How to avoid artifacts
- (2013) Sivan Tzadok et al. ANALYTICAL BIOCHEMISTRY
- SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
- (2013) D. H. Shin et al. CANCER RESEARCH
- Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
- (2013) E. B. Butler et al. CANCER RESEARCH
- MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells
- (2013) Tao Yang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity
- (2013) Leibo Xu et al. JOURNAL OF HEPATOLOGY
- MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma
- (2013) Ning Wang et al. Molecular Cancer
- MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment
- (2013) Fan Yang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Clinical Trials in Hepatocellular Carcinoma: An Update
- (2013) Ying-Chun Shen et al. Liver Cancer
- Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell
- (2012) Ning Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2
- (2012) Francesca Fornari et al. JOURNAL OF PATHOLOGY
- DNA Methylation-regulated miR-193a-3p Dictates Resistance of Hepatocellular Carcinoma to 5-Fluorouracil via Repression of SRSF2 Expression
- (2011) Kelong Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
- (2010) Francesca Fornari et al. CANCER RESEARCH
- Hepatitis C Virus Proteins Modulate MicroRNA Expression and Chemosensitivity in Malignant Hepatocytes
- (2010) C. Braconi et al. CLINICAL CANCER RESEARCH
- The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
- (2010) Satoshi Shimizu et al. JOURNAL OF HEPATOLOGY
- MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
- (2009) Shoumei Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3
- (2008) Wing Pui Tsang et al. APOPTOSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More